跳至主要内容
临床试验/DRKS00016907
DRKS00016907已完成未知

Evaluation of baseline fracture risk in younger postmenopausal women with breast cancer using different risk assessment methods - EPI -OSt

niv.Klinik für Nuklearmedizin0 个研究点目标入组 343 人开始时间: 2019年3月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
343

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
Female

入选标准

  • Study population: postmenopausal women between 50-59 years of age who receive aromatase inhibitor therapy due to hormone receptor-positive breast cancer and receive a bone density measurement within the first 3 months.
  • Control group: healthy, postmenopausal women between 50-59 years of age receiving bone density measurement.

排除标准

  • Women younger than 50 or older than 59 years,
  • premenopausal women,
  • women who receive a specific antiosteoporotic therapy,
  • women who do not want to give informed consent,
  • women with a BMI>30kg/m² or a BMI <15 kg/m², because in these cases an exact TBS measurement is not possible.

研究者

发起方
niv.Klinik für Nuklearmedizin

相似试验